Prescription Pricing for the People Act of 2023

United States118th CongressS-113Senate
Updated: Mar 1, 2023

Summary

Prescription Pricing for the People Act of 20 2 3 This bill requires the Federal Trade Commission (FTC) to report about anticompetitive practices and other trends within the pharmaceutical supply chain that may impact the cost of prescription drugs. The FTC also must provide recommendations to increase transparency in the supply chain and prevent anticompetitive practices.

Bill texts

Available versions
View official text

2 versions available

All available records shown.

Timeline

  1. Read twice and referred to the Committee on the Judiciary.

    Senate

  2. Committee on the Judiciary. Ordered to be reported with an amendment in the nature of a substitute favorably.

    Senate

  3. Placed on Senate Legislative Calendar under General Orders. Calendar No. 19.

    Senate

  4. Committee on the Judiciary. Reported by Senator Durbin with an amendment in the nature of a substitute. Without written report.

    Senate